Tag: Metreleptin [Myalept]

By Posted on Posted in Allelic Variant, Gene Expression, Genetic Background, Genetic Predisposition, Genetic Susceptibility, New Research, Personomics, Thasso Post, Theragenomic Medicine Tagged with , , , , , , , , , ,

June 25, 2019 – The global obesity epidemic is so far-reaching it now has an overarching name: globesity (obviously derived from global obesity).  Very interesting questions arise in this context such as are there glocalized (global and or local) factors …

Genetic aspects of globesity: Glocalized or not? Read more »

By Posted on Posted in Genetic Background, New Drug Approval, Rare Diseases Tagged with , , , , , , , , ,

March 19, 1014 – We just learned from a recent Press Release by the American Food and Drug Administration (FDA) on the approval of Metreleptin [Myalept] to treat leptin deficiency. Read the article below: On February 24, 2014, the U.S. …

FDA approves Metreleptin [Myalept] to treat rare metabolic disease Read more »